Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trialFrederick J. Raal, Stanley T. Crooke, Raúl D. Santos et al.|The Lancet|2010Cited by 905
Apolipoprotein B Synthesis Inhibition With Mipomersen in Heterozygous Familial HypercholesterolemiaEvan A. Stein, Mary P. McGowan, Robert Dufour et al.|Circulation|2012Cited by 299
Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteinsDiane L. Tribble, Ronald M. Krauss, Diane M Lewis et al.|The American Journal of Medicine|2001Cited by 185